Tenax Therapeutics Inc. (TENX)
NASDAQ · Healthcare
Tenax Therapeutics Inc. Operating Income 2011–2025
Tenax Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Tenax Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -16.6 M, a 46.17% increase year-over-year.
- Tenax Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -35.2 M, a 311.49% increase year-over-year.
- Tenax Therapeutics Inc. annual operating income for 2025 was -56.4 M, a 189.24% increase from 2024.
- Tenax Therapeutics Inc. annual operating income for 2024 was -19.5 M, a 62.97% decrease from 2016.
- Tenax Therapeutics Inc. annual operating income for 2016 was -52.7 M, a 255.35% increase from 2015.
- Tenax Therapeutics Inc. annual operating income for 2015 was -14.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tenax Therapeutics Inc. Operating Income — FAQ
Tenax Therapeutics Inc. (TENX) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Tenax Therapeutics Inc.'s operating income?
Tenax Therapeutics Inc. (TENX) reported operating income of -$56M for fiscal 2025.
Where can I see TENX's operating income history?
The chart and table above show Tenax Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.